Pay in 4 interest-free payments of $5.85 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
BPC-157 promotes VEGFR2 receptor internalization, triggering phosphorylation of Akt at specific sites (Ser473 and Thr308)
Comparison with Standard Treatments Studies comparing BPC-157 to becaplermin (the active ingredient in Regranex, an FDA-approved treatment for diabetic foot ulcers) found BPC-157 produced superior results in several parameters
Because these compounds are naturally occurring peptides with restricted patentability, opportunities for intellectual property protection and industry-sponsored development are limitedposing substantial barriers to the resource-intensive clinical investigations required to confirm therapeutic efficacy and long-term safety
The detailed BPC-157 vs TB-500 comparison helps determine when individual peptides suffice versus when stacking adds value
World J Stem Cells
US$ 28.24
US$ 22.52
US$ 20.93
US$ 23.59
.webp)
US$ 26.48
